Condition
LONGEVITY 1
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07220473Phase 2Recruiting
Tirzepatide to Slow Biological Aging
NCT06372054Recruiting
TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models
NCT06268132RecruitingPrimary
Longevity in Russia
NCT04840381CompletedPrimary
Dietary Habits and Lifestyle of Nonagenarians and Centenarians in the Italian Abruzzo Region
NCT03541460CompletedPrimary
Israeli Multi Ethnic Centenarian Project
Showing all 5 trials